TCL Archive South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study. February 11, 2000
TCL Archive Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed May 10, 2013
TCL Archive Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget December 7, 2012
TCL Archive Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival October 29, 2010
